Authors:
Strobl, B
Arulampalam, V
Is'harc, H
Newman, SJ
Schlaak, JF
Watling, D
Costa-Pereira, AP
Schaper, F
Behrmann, I
Sheehan, KCF
Schreiber, RD
Horn, F
Heinrich, PC
Kerr, IM
Citation: B. Strobl et al., A completely foreign receptor can mediate an interferon-gamma-like response, EMBO J, 20(19), 2001, pp. 5431-5442
Authors:
Dupuis, S
Dargemont, C
Fieschi, C
Thomassin, N
Rosenzweig, S
Harris, J
Holland, SM
Schreiber, RD
Casanova, JL
Citation: S. Dupuis et al., Impairment od mycobacterial but not viral immunity by a germline human STAT1 mutation, SCIENCE, 293(5528), 2001, pp. 300-303
Authors:
Yin, L
Wu, L
Wesche, H
Arthur, CD
White, JM
Goeddel, DV
Schreiber, RD
Citation: L. Yin et al., Defective lymphotoxin-beta receptor-induced NF-kappa B transcriptional activity in NIK-deficient mice, SCIENCE, 291(5511), 2001, pp. 2162-2165
Authors:
Shankaran, V
Ikeda, H
Bruce, AT
White, JM
Swanson, PE
Old, LJ
Schreiber, RD
Citation: V. Shankaran et al., IFN gamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity, NATURE, 410(6832), 2001, pp. 1107-1111
Authors:
Hu, JB
Roy, SK
Shapiro, PS
Rodig, SR
Reddy, SPM
Platanias, LC
Schreiber, RD
Kalvakolanu, DV
Citation: Jb. Hu et al., ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-dependent gene transcription in response to interferon-gamma, J BIOL CHEM, 276(1), 2001, pp. 287-297
Authors:
Luker, KE
Pica, CM
Schreiber, RD
Piwnica-Worms, D
Citation: Ke. Luker et al., Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells, CANCER RES, 61(17), 2001, pp. 6540-6547
Citation: V. Shankaran et Rd. Schreiber, The interferons: Basic biology and therapeutic potential, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 220-239
Authors:
Mumberg, D
Monach, PA
Wanderling, S
Philip, M
Toledano, AY
Schreiber, RD
Schreiber, H
Citation: D. Mumberg et al., CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma (vol 96, pg 8633, 1999), P NAS US, 97(5), 2000, pp. 2397-2397
Authors:
Doffinger, R
Jouanguy, E
Dupuis, S
Fondaneche, MC
Stephan, JL
Emile, JF
Lamhamedi-Cherradi, S
Altare, F
Pallier, A
Barcenas-Morales, G
Meinl, E
Krause, C
Pestka, S
Schreiber, RD
Novelli, F
Casanova, JL
Citation: R. Doffinger et al., Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guerin and Mycobacterium abscessus infection, J INFEC DIS, 181(1), 2000, pp. 379-384
Authors:
Puglielli, MT
Browning, JL
Brewer, AW
Schreiber, RD
Shieh, WJ
Altman, JD
Oldstone, MBA
Zaki, SR
Ahmed, R
Citation: Mt. Puglielli et al., Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathway, NAT MED, 5(12), 1999, pp. 1370-1374
Authors:
Jouanguy, E
Lamhamedi-Cherradi, S
Lammas, D
Dorman, SE
Fondaneche, MC
Dupuis, S
Doffinger, R
Altare, F
Girdlestone, J
Emile, JF
Ducoulombier, H
Edgar, D
Clarke, J
Oxelius, VA
Brai, M
Novelli, V
Heyne, K
Fischer, A
Holland, SM
Kumararatne, DS
Schreiber, RD
Casanova, JL
Citation: E. Jouanguy et al., A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection, NAT GENET, 21(4), 1999, pp. 370-378
Authors:
Mumberg, D
Monach, PA
Wanderling, S
Philip, M
Toledano, AY
Schreiber, RD
Schreiber, H
Citation: D. Mumberg et al., CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma, P NAS US, 96(15), 1999, pp. 8633-8638
Authors:
Nakamoto, Y
Guidotti, LG
Pasquetto, V
Schreiber, RD
Chisari, FV
Citation: Y. Nakamoto et al., Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice. (vol 158, pg 5692, 1997), J IMMUNOL, 163(2), 1999, pp. 1092-1092
Authors:
Riley, JK
Takeda, K
Akira, S
Schreiber, RD
Citation: Jk. Riley et al., Interleukin-10 receptor signaling through the JAK-STAT pathway - Requirement for two distinct receptor-derived signals for anti-inflammatory action, J BIOL CHEM, 274(23), 1999, pp. 16513-16521